Why I believe AI / SI will unlock cures for every Cancer within the next five to ten years ears - PART 1:
For decades, cancer researchers have confronted a seemingly impossible problem: the biological complexity of cancer is so enormous that no individual scientist, research team, or even the entire scientific community can systematically explore all possible therapeutic solutions.
Consider what happens inside a single tumor. Thousands of genes, proteins, metabolites, and signaling pathways interact across millions or billions of cells. Then cancer cells constantly evolve, acquiring mutations, adapting to their environments, escaping immune surveillance, and developing resistance to treatments. Their behavior is further influenced by surrounding immune cells, blood vessels, fibroblasts, and the metabolic conditions within the tumor.
And every patient's cancer is different.
This creates an astronomical number of possible biological states and therapeutic interventions. Even when scientists identify a promising molecular target, they must determine whether interfering with it will actually kill the cancer, whether healthy tissues depend on the same mechanism, and whether the tumor will eventually escape.
Historically, we’ve approached this problem through relatively very slow cycles of hypothesis generation, experimentation, and clinical testing. We investigate a limited number of targets, screen a fraction of possible compounds, and spend years determining whether a treatment works.
Now imagine what happens when the intelligence available to solve these problems increases exponentially.
I believe the next five to ten years will bring superintelligence systems whose scientific reasoning, computational modeling, and experimental capabilities will vastly exceed those of today's best researchers put together!
The implications for cancer research will be profound. Here is the part 1 of how this can be achieved:
Virtual cells:
One of the most exciting developments will be the emergence of virtual cells, or computational models designed to predict how living cells behave and respond to interventions
Imagine an AI system that can represent a cancer cell's molecular machinery, including its genetic mutations, gene expression, protein interactions, metabolism, and signaling networks. Instead of testing one drug at a time, scientists could ask the model what would happen if they inhibited a particular protein, activated a specific immune pathway, edited a gene, or administered several treatments simultaneously.
Now extend that capability to millions of virtual cancer cells representing different tumor subpopulations, together with immune cells and healthy tissues.
We could potentially simulate how an entire tumor responds to treatment, how resistant populations emerge, and how different interventions affect normal cells!
This is the vision of increasingly comprehensive biological foundation models: AI systems trained on extensive molecular and experimental data that learn generalizable principles of cellular behavior.
The extraordinary opportunity is that such systems could eventually discover therapeutic mechanisms that we have never considered because we lack that computational capability. They might identify previously unrecognized combinations of molecular vulnerabilities, predict how to overcome resistance, and design interventions that exploit subtle differences between malignant and healthy cells.
Today's virtual-cell models are still very limited approximations of biology. But their predictive accuracy and scope will improve dramatically, and they will become powerful engines, accelerating precise therapeutic discoveries by magnitudes faster!
Part 2 will be about the digital twins. To be continued.
